EQS-Adhoc

Achiko AG: Achiko gründet ein Joint Venture mit PT Indonesia Farma Medis für die Produktion und Distribution seiner Covid-19-Testplattform in Indonesien - Seite 4

Achiko hält die exklusiven Vermarktungsrechte an der Technologie von Regenacellx.sl, die Project Gumnuts zugrunde liegt. Sie kann sowohl für den Nachweis aller bekannten Varianten von Covid-19 als auch für andere Krankheitserreger verwendet werden. Achiko freut sich auf den Abschluss der behördlichen Zulassung und darauf, die Technologie so schnell wie möglich auf den Markt zu bringen und sie in einer Reihe von Testkits und anderen Assay-Formaten anzuwenden.

Unser Hauptsitz befindet sich in Zürich und wir verfügen über Büros in Hongkong, Jakarta, Singapur und Seoul.
http://www.achiko.com

About PT Indonesia Farma Medis
PT Indonesia Farma Medis ("PIFM") is a medical device and pharmaceutical distribution company with a large network of relationships and distribution channels that includes hospitals, pharmacies and clinics across the main islands of Indonesia.

PIFM provides supply chain solutions for distributing medical products and helps companies seeking market entry navigate the complexities of the Indonesian market.
https://indofarmamedis.com

About PT Mitra Asa Pratama
Mitra Asa Pratama collaborates with various international medical device brands to bring innovations to market and has been improving the overall healthcare technology in Indonesia for more than 20 years. With an extensive distribution network built by working closely with our sub-distributor partners, we cover hospitals, clinics, public health centers and offices, medical professionals, as well as the retail market.

It has been a long-standing part of our strategic vision to be able to build a vertically integrated company, where every business unit shares the same dedication to customer service. We firmly believe that service levels must always exceed expectations so that our clients, the medical professionals, can concentrate on the very important business of caring for patients.
https://mitraasa.co.id/

About PT Pharos Indonesia
PT Pharos Indonesia is a major regional pharmaceutical company that develops and markets innovative products in Indonesia and other countries in South-East Asia.

The company was established on 30 September 1971 by Dr. Eddie Lembong, a visionary entrepreneur who wanted to build a modern, efficient, high quality, Indonesian pharmaceutical company. Dr. Lembong's plan was realized early and today Pharos remains one of Indonesia's leading pharmaceutical companies.